Main public logs
Combined display of all available logs of CAMIH. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
- 13:14, 4 November 2024 JDoerfler talk contribs deleted page Mücke, R (content was: "{{Author}}", and the only contributor was "Lbordihn" (talk))
- 13:12, 4 November 2024 JDoerfler talk contribs deleted page Tan, Y, Li, P (content was: "{{Author}}", and the only contributor was "EProba" (talk))
- 13:11, 4 November 2024 JDoerfler talk contribs deleted page Asfour, I; El Shazlyn, S; Fayek, MH; Hegab, HM; Raouf, S; Moussa, MAR (content was: "{{Author}}", and the only contributor was "Lbordihn" (talk))
- 15:12, 29 October 2024 JDoerfler talk contribs created page Project:About (Created page with "='''What is CAMIH?'''= CAMIH, short for Complementary and Alternative Medicine Insights Hub, is a database offering up-to-date evidence from randomized controlled trials on complementary approaches and methods for treating oncology patients. Each study has been meticulously reviewed and critically evaluated for methodological rigor using the ''Cochrane Risk of Bias Tool 2.0''. This approach ensures that the database not only provides a comprehensive collection of eviden...")
- 07:37, 29 October 2024 JDoerfler talk contribs deleted page Stratton, MS; Algotar, AM; Ranger-Moore, J; Stratton, SP; Slate, EH; Hsu, C; Thompson, PA; Clark, LC; Ahmann, FR (content was: "{{Author}}", and the only contributor was "Lbordihn" (talk))
- 10:15, 6 September 2024 JDoerfler talk contribs created page Okabayashi et al. (2020): L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients (Created page with "{{Reference |Reference=Publication: L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients }} {{Study Note}} =Brief summary= In this study, patients who had their liver removed due to liver cancer or biliary tract disease were included. The patients were randomly divided into 2 groups, with one group receiving carnitine for 2 weeks, while the other group received no additional intervention. After the surgery, a slightly shorter hospital stay was obs...")
- 09:38, 6 September 2024 JDoerfler talk contribs created page Publication: L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients (Created page with "{{Publication |Title=L-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients; Journal |Topic=Carnitine |Author=Okabayashi T; Sui K; Mastumoto T; Iwata J; Morita S; Iiyama T; Shimada Y |Year=2020 |Journal=Journal of parenteral and enteral nutrition |DOI=https://doi.org/10.1002/jpen.1720 |Authors Abstract=Background and aims: The effect of perioperative treatment with L-carnitine in hepatectomized patients is unclear. The objectiveof the current study...")
- 08:12, 6 September 2024 JDoerfler talk contribs created page Hershman et al. (2018): Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine (Created page with "{{Reference |Reference=Publication: Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine }} {{Study Note}} =Brief summary= This study is a follow-up study of the 2013 study [Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy], in which the data of the patients are reported afte...")
- 08:10, 6 September 2024 JDoerfler talk contribs created page Publication: Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine (Created page with "{{Publication |Title=Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L Carnitine |Topic=Carnitine |Author=Hershman DL; Unger JM; Crew KD; Till C; Greenlee H; Minasian LM; Moinpour CM; Lew DL; Fehrenbacher L; Wade JL III; Wong SF; Fisch MJ; Henry NL; Albain KS |Year=2018 |Journal=Journal of the National Cancer |DOI=https://doi.org/10.1093/jnci/djx259 |Authors Abstract=Background: Chemotherapy-induced peripheral neuropathy (CI...")
- 12:28, 3 September 2024 JDoerfler talk contribs created page Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy (Created page with "{{Reference |Reference=Publication: Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy }} {{Study Note |Study Note=? }} =Brief summary= This study evaluated data from 83 patients who were randomly divided into 3 arms: one arm received carnitine in addition to chemotherapy, another arm received silymarin (from milk thistle fruits) in addition to chemotherapy, and the third arm received...")
- 12:08, 3 September 2024 JDoerfler talk contribs created page Publication: Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy (Created page with "{{Publication |Title=Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy |Topic=Carnitine |Author=Zalat ZA; Elewa HA; Abdel-Latif M; Alm El-Din MA; Kohaf NA |Year=2020 |Journal=Journal of Bioscience and Applied Research |DOI=https://doi.org/10.21608/jbaar.2020.119755 |Authors Abstract=Aim: Anthracycline-induced cardiotoxicity is the most common constraint of its use in the treatment of...")
- 07:57, 3 September 2024 JDoerfler talk contribs created page Sun et al. (2016): A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy (Created page with "{{Reference |Reference=Publication: A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy }} {{Study Note |Study Note=? }} =Brief summary= This study shows the influence of acetyl-L-carnitine (ALC) on peripheral neuropathy as a result of chemotherapy. A total of 239 subjects participated in the study, of which 118 patients received ALC every day for 8 weeks (intervention arm) and...")
- 07:55, 3 September 2024 JDoerfler talk contribs created page Publication: A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy (Created page with "{{Publication |Title=A prospective study to evaluate the efficacy and safety of oral acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy |Topic=Carnitine |Author=Sun Y; Shu Y; Liu B; Liu P; Wu C; Zheng R; Zhang X; Zhuang Z; Deng Y; Zheng L; Xu Q; Jiang B; Ouyang X; Gao J; Xu N; Li X; Jiang S; Liang C; Yao Y |Year=2016 |Journal=Experimental and therapeutic medicine |DOI=https://doi.org/10.3892/etm.2016.3871 |Authors Abstract=The present stud...")
- 13:37, 26 July 2024 JDoerfler talk contribs created page Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia (Created page with "{{Reference |Reference=Publication: Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia }} {{Study Note}} =Brief summary= This study was conducted with 332 patients and investigated the influence of carnitine, MPA/MA, EPA, thalidomide and a combination medication (carnitine + MPA/MA + EPA + thalidomide) on weight (fat mass and muscle mass) over 16 weeks in patients with acute weight loss due to cancer. The results...")
- 13:34, 26 July 2024 JDoerfler talk contribs created page Publication: Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia (Created page with "{{Publication |Title=Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia |Topic=Carnitine |Author=Mantovani, G; Macciò, A; Madeddu, C; Serpe, R; Massa, E; Dessì, M; Panzone, F; Contu, P |Year=2010 |Journal=The oncologist |DOI=https://doi.org/10.1634/theoncologist.2009-0153 |Authors Abstract=Purpose. A phase III, randomized study was carried out to establish the most effective and safest treatment to improve the...")
- 12:28, 23 July 2024 JDoerfler talk contribs created page Kraft et al. (2012): L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (Created page with "{{Reference |Reference=Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial }} {{Study Note}} =Brief summary= This study included 72 patients with advanced pancreatic cancer who were randomly and fairly evenly divided into two groups. One group received the carnitine and the other group the placebo. The authors investigated the influence of carnitine on the weight caused by the disease, as well as the influence...")
- 12:09, 23 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial (Created page with "{{Publication |Title=L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial |Topic=Carnitine |Author=Kraft, M; Kraft, K; Gärtner, S; Mayerle, J; Simon, P; Weber, E; Schütte, K; Stieler, J; Koula-Jenik, H; Holzhauer, P; Gröber, U; Engel, G; Müller, C; Feng, YS; Aghdassi, A; Nitsche, C; Malfertheiner, P; Patrzyk, M; Kohlmann, T; Lerch, MM |Year=2012 |Journal=Deutsche Zeitschrift für Onkologie |DOI=http://www.nutritionj.com/...")
- 09:30, 23 July 2024 JDoerfler talk contribs created page Koyama et al. (2017): Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Reference |Reference=Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients }} {{Study Note}} =Brief summary= The study investigated the influence of carnitine on the inflammatory and insulin response in patients following surgery for gastric or colorectal cancer. Eight patients were randomly assigned to the control group, who received the usual...")
- 09:27, 23 July 2024 JDoerfler talk contribs created page Publication: Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients (Created page with "{{Publication |Title=Intravenous Carnitine Administration in Addition to Parenteral Nutrition With Lipid Emulsion May Decrease the Inflammatory Reaction in Postoperative Surgical Patients |Topic=Carnitine |Author=Koyama Y; Moro K; Nakano M; Miura K; Nagahashi M; Kosugi S-i; Tsuchida J; Ikarashi M; Nakajima M; Ichikawa H; Hanyu T; Shimada Y; Sakata J; Kameyama H; Kobayashi T; Wakai T |Year=2017 |Journal=Journal of clinical medicine research |DOI=https://doi.org/10.14740/j...")
- 12:25, 22 July 2024 JDoerfler talk contribs created page Hershman et al. (2013): Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Reference |Reference=Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy }} {{Study Note}} =Brief summary= This large-scale study, initially involving 409 breast cancer patients, focused primarily on the effect of carnitine on peripheral neuropathy (an increased toxicity in the brain that negatively affects all functions of the body) caused...")
- 12:12, 22 July 2024 JDoerfler talk contribs created page Publication: Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy (Created page with "{{Publication |Title=Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy |Topic=Carnitine |Author=Hershman, DL; Unger, JM; Crew, KD; Minasian, LM; Awad, D; Moinpour, CM; Hansen, L; Lew, DL; Greenlee, H; Fehrenbacher, L; Wade, JL; Wong, SF; Hortobagyi, GN; Meyskens, FL; Albain, KS |Year=2013 |Journal=Journal of clinical oncology: official journal of the Am...")
- 08:51, 22 July 2024 JDoerfler talk contribs created page Cruciani et al. (2012): L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial }} {{Study Note}} =Brief summary= 376 patients with different types of cancer took part in this study to investigate carnitine on tiredness/fatigue caused by cancer or the associated chemotherapy and medication. They were randomly assigned to 2 groups, one...")
- 08:46, 22 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial (Created page with "{{Publication |Title=L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial |Topic=Carnitine |Author=Cruciani, RA; Zhang, JJ; Manola, J; Cella, D; Ansari, B; Fisch, MJ |Year=2012 |Journal=Journal of clinical oncology: official journal of the American Society of Clinical Oncology |DOI=https://doi.org/10.1200/JCO.2011.40.2180 |Authors Abstract=Pur...")
- 14:18, 16 July 2024 JDoerfler talk contribs created page Cruciani et al. (2009): L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study }} {{Study Note}} =Brief summary= The study investigated the impact of carnitine on fatigue/exhaustion caused by cancer and the associated chemotherapy and medication. A total of 33 patients with various cancers and a carnitine deficiency caused by the treatment were randomly assigned to two groups. One group...")
- 13:38, 16 July 2024 JDoerfler talk contribs created page Publication: L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study (Created page with "{{Publication |Title=L-Carnitine Supplementation in Patients with Advanced Cancer and Carnitine Deficiency: A Double-Blind, Placebo-Controlled Study |Topic=Carnitine |Author=Cruciani, RA; Dvorkin, ED; Homel, P; Culliney, B; Malamud, S; Lapin, J; Portenoy, RK; Esteban-Cruciani, N |Year=2009 |Journal=Journal of pain and symptom management |DOI=https://doi.org/10.1016/j.jpainsymman.2008.03.021 |Authors Abstract=Carnitine deficiency is prevalent in populations with chronic i...")
- 11:57, 16 July 2024 JDoerfler talk contribs created page Cavallini et al. (2005): Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Reference |Reference=Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy }} {{Study Note}} =Brief summary= This study investigated the effect of carnitine as an adjuvant to the usual medication (sildenafil) in erectile dysfunction following prostatectomy. Ninety-six patients participated in the study, of which 29 were in the control...")
- 10:00, 16 July 2024 JDoerfler talk contribs created page Publication: Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy (Created page with "{{Publication |Title=Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy |Topic=Carnitine |Author=Cavallini, G; Modenini, F; Vitali, G; Koverech, A |Year=2005 |Journal=Urology |DOI=https://doi.org/10.1016/j.urology.2005.05.014 |Authors Abstract=Objectives To determine whether propionyl-l-carnitine (PLC) plus acetyl-l-carnitine (ALC) improves the e...")
- 09:12, 16 July 2024 JDoerfler talk contribs created page Ryan et al. (2013): Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Reference |Reference=Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients }} {{Study Note}} =Brief summary= =Study Design= In this study, breast cancer patients were examined during radiotherapy, with one half taking curcumin alongside radiotherapy and the other half taking a placebo. In the curcumin group, the severity of radiodermatitis (a common skin disease associated with ra...")
- 07:22, 16 July 2024 JDoerfler talk contribs created page Publication: Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients (Created page with "{{Publication |Title=Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients |Topic=Curcumin |Author=Ryan, JL; Heckler, CE; Ling, M; Katz, A; Williams, JP; Pentland, AP; Morrow, GR |Year=2013 |Journal=Journal of Radiation Research |DOI=https://doi.org/10.1667/RR3255.1 |Authors Abstract=Radiation dermatitis occurs in approximately 95% of patients receiving radiotherapy (RT) for breast cancer. We con...")
- 14:18, 15 July 2024 JDoerfler talk contribs created page Rao et al. (2014): The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Reference |Reference=Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study }} {{Study Note}} =Brief summary= This study investigated the efficacy of a curcumin mouth rinse compared to a povidone-iodine mouth rinse in patients with head and neck cancer during radiotherapy. Throughout radiotherapy, mucositis (an inflammation of the mucosa, a common a...")
- 13:47, 15 July 2024 JDoerfler talk contribs created page Publication: The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study (Created page with "{{Publication |Title=The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study |Topic=Curcumin |Author=Rao, S; Dinkar, C; Vaishnav, LK; Rao, P; Rai, MP; Fayad, R; Baliga, MS |Year=2014 |Journal=Integrative Cancer Therapies |DOI=https://doi.org/10.1177/1534735413503549 |Authors Abstract=Purpose. Radiation-induced oral mucositis is an acute morbidity seen in patients u...")
- 13:15, 15 July 2024 JDoerfler talk contribs created page Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Reference |Reference=Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer }} {{Study Note}} =Brief summary= In this study, patients with head and neck tumors were examined during radiotherapy. The patients were instructed to apply a gel to the entire oral cavity 3 times a day, with half receiving a curcumin gel and the other half a placebo gel. There were more cases of severe mucositis (an inf...")
- 13:09, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer (Created page with "{{Publication |Title=The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer |Topic=Curcumin |Author=Mansourian, A; Amanlou, M; Shirazian, Sh; Moosavian Jahromi, Z; Amirian, A |Year=2015 |Journal=International Journal of Radiation Research |DOI=https://doi.org/10.7508/ijrr.2015.03.011 |Authors Abstract=Background: Different treatment and protective approaches for radiation-induced oral mucositis have been pract...")
- 12:30, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Reference |Reference=Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo cap...")
- 12:29, 15 July 2024 JDoerfler talk contribs created page Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study (Created page with "{{Publication |Title=Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Hejazi, E; Ehtejab, G; Hara, N |Year=2016 |Journal=Nutrition and Cancer |DOI=https://doi.org/10.1080/01635581.2016.1115527 |Authors Abstract=Curcumin is an antioxidant agent with both radiosensitizing and radioprot...")
- 12:23, 15 July 2024 JDoerfler talk contribs created page Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Reference |Reference=Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo capsules instead. In the first study of XX, the quality...")
- 11:56, 15 July 2024 JDoerfler talk contribs created page Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer (Created page with "{{Publication |Title=A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Ehtejab, G |Year=2013 |Journal=Journal of Cancer Science and Therapy |DOI=http://dx.doi.org/10.4172/1948-5956.1000223 |Authors Abstract=Background: Patients with prostate cancer who accede to radiation therapy usually experience several side effects and these toxicit...")
- 09:41, 15 July 2024 JDoerfler talk contribs created page Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Reference |Reference=Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study }} {{Study Note}} =Brief summary= Cisplatin is an effective chemotherapeutic agent. However, cisplatin is toxic to the outer hair cells of the ears and can cause hearing loss in patients receiving this therapy. In this study, the researchers tested the effect of Ginkgo biloba extract at a dose of 120 mg twice daily to prevent damage to...")
- 09:40, 15 July 2024 JDoerfler talk contribs created page Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study (Created page with "{{Publication |Title=The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study |Topic=Ginkgo |Author=Dias, MA; Sampaio, ALL; Venosa, AR; Meneses, EA; Oliveira, CACP |Year=2015 |Journal=International Tinnitus Journal |DOI=https://doi.org/10.5935/0946-5448.20150003 |Authors Abstract=Objective: The purpose of this study was to evaluate, by using distortion product otoacoustic emission test, the action of Ginkgo biloba extract 761,...")
- 08:53, 15 July 2024 JDoerfler talk contribs created page Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Reference |Reference=Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 }} {{Study Note}} =Brief summary= Differentiated thyroid cancer (DTC) is a type of thyroid cancer that has developed in the cells of the thyroid gland that are responsible for the production of thyroid hormones. DTC is usually treated by removing the thyroid gland followed by radio...")
- 08:49, 15 July 2024 JDoerfler talk contribs created page Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 (Created page with "{{Publication |Title=The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 |Topic=Ginkgo |Author=Dardano, A; Ballardin, M; Caraccio, N; Boni, G; Traino, C; Mariani, G; Ferdeghini, M; Barale, R; Monzani, F |Year=2012 |Journal=Thyroid |DOI=https://doi.org/10.1089/thy.2010.0398 |Authors Abstract=Background: Radioiodine (131I) therapy is usually performed in patients with d...")
- 08:27, 15 July 2024 JDoerfler talk contribs deleted page Publication: Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors (content was: "{{Publication |Title=Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial |Topic=Boswellia serrata |Author=Kirste, S; Treier, M; Wehrle, SJ; Becker, G; Abdel-Tawab, M; Gerbeth, K; Hug, MJ; Lubrich, B; Grosu, AL; Momm, F |Year=2011 |Journal=Wiley Online Library |DOI=https://doi.org/10.1002/cncr.25945 |Authors Abstract=BACKGROUND: Patients irradiated for brain tumors often suffer...")
- 09:15, 12 July 2024 JDoerfler talk contribs created page Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 (Created page with "{{Reference |Reference=Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer }} {{Study Note}} =Brief summary= Patients receiving chemotherapy often describe a decline in cognitive function (known as "chemo brain") that remains for months or years after chemotherapy has ended. As breast cancer survival rates improve, more attention is being paid to this side effect on...")
- 08:56, 12 July 2024 JDoerfler talk contribs created page Publication: The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer (Created page with "{{Publication |Title=The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer |Topic=Ginkgo |Author=Barton, DL; Burger, K; Novotny, PJ; Fitch, TR; Kohli, S; Soori, G; Wilwerding, MB; Sloan, JA; Kottschade, L.A; Rowland, KM; Dakhil, SR; Nikcevich, DA; Loprinzi, CL |Year=2013 |Journal=Support Care Cancer |DOI=https://doi.org/10.1007/s00520-012-1647-9 |Authors Abstract=Purpose Patient...")
- 07:39, 12 July 2024 JDoerfler talk contribs created page Villani et al. (2016): Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Reference |Reference=Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=? |Centralized=? |Blinding=? |Is randomized=Yes |Cross-over=No |Number of arms=-999 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=-999 |Analysis=?...")
- 07:37, 12 July 2024 JDoerfler talk contribs created page Publication: Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial (Created page with "{{Publication |Title=Vitamin E neuroprotection against cisplatin ototoxicity: Preliminary results from a randomized, placebo-controlled trial |Topic=Vitamin E |Author=Villani, V; Zucchella, C; Cristalli, G; Galie, E; Bianco, F; Giannarelli, D; Carpano, S; Spriano, G; Pace, A |Year=2016 |Journal=Head and Neck |DOI=https://doi.org/10.1002/hed.24396 |Authors Abstract=Background. Few studies have investigated the effect of vitamin E in reducing the cisplatin (CDDP)-induced...")
- 08:12, 11 July 2024 JDoerfler talk contribs created page Upadhyaya et al. (2017): Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Reference |Reference=Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial }} {{Study Note |Study Note=? }} =Brief summary= In this study, the protective effect of vitamin E on radiotherapy-induced functional impairment of the salivary glands (auricular and submandibular salivary glands) in patients with thyroid cancer was investigated. The patients were divided into...")
- 08:01, 11 July 2024 JDoerfler talk contribs created page Publication: Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial (Created page with "{{Publication |Title=Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differential thyroid cancer: A randomized-controlled trial |Topic=Vitamin E |Author=Upadhyaya, A; Zhou, P; Meng, Z; Wang, P; Zhang, G; Jia, Q; Tan, J; Li, X; Hu, T; Liu, N; Wang, S; Liu, X; Wang, H; Zhang, C; Zhao, F; Yan, Z; Wang, X; Zhang, X; Zhang, W |Year=2017 |Journal=Nuclear Medicine Communications |DOI=https://doi.org/10.1097/MNM.0000000000000727 |Authors Abst...")
- 14:10, 9 July 2024 JDoerfler talk contribs created page Publication: The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Publication |Title=The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial |Topic=Vitamin E |Author=Shamsaei G; Ahmadzadeh A; Mehraban N |Year=2017 |Journal=Jundishapur Journal Of Natural Pharmaceutical Products |DOI=https://doi.org/10.5812/jjnpp.65027 |Authors Abstract=Background: Chemotherapy-induced neuropathy is one of the most severe complications of cancer drug therapies causing a number of proble...")
- 14:07, 9 July 2024 JDoerfler talk contribs created page Shamsaei et al. (2017): The Vitamin E Preventive Effect on Taxol-Induced Neuropathy Among Patients With Breast Cancer: A Randomized Clinical Trial (Created page with "{{Reference |Reference=? }} {{Study Note |Study Note=? }} =Brief summary= =Study Design= {{Study Design (RCT) |Perspective=Prospective |Centralized=Monocentric |Blinding=Single |Is randomized=Yes |Cross-over=No |Number of arms=2 }} =Study characteristics= {{RCT study general properties |Inclusion criteria=? |Exclusion criteria=? |N randomized=70 |Analysis=ITT Analysis |Specifications on analyses=ITT not specified, but no drop-out reported. |Countries of data collectio...")